Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

EU flag

Europe gains access to first stem cell drug

Chiesi's Holoclar has been given the green light for a rare eye condition

- PMLiVE

Communicating value

The global recession has changed the way the industry needs to market its medicines

- PMLiVE

Celgene gets first-line myeloma approval for Revlimid

Approved in the EU and US for newly-diagnosed patients

- PMLiVE

Boehringer in breach over beer drinking, lederhosen presentation

German firm earns PMCPA’s wrath over ‘inappropriate’ conference speakers

Eli Lilly HQ

Lilly sets back evacetrapib data deadline

Cholesterol drug trials extended by six months

- PMLiVE

Smith & Nephew invests in new tech that can ‘see’ through skin

Hopes to use tech for detecting skin cancer and help with wound care

- PMLiVE

Advagraf shows survival increase for liver transplant patients

Astellas drug shows significant improvement in study published in the AJT

- PMLiVE

NICE recommends Ozurdex for diabetic eye condition

Draft guidance cites implant as option for patients with diabetic macular oedema

- PMLiVE

Sanofi’s CEO search ends as Bayer’s Brandicourt takes the job

He will begin leading the French pharma company on April 2

- PMLiVE

Norgine close to final yes from NICE on Targaxan

Medicine is licenced to prevent a brain condition caused by liver failure

- PMLiVE

Roche’s Zelboraf combination to receive priority FDA review

US regulator to assess drug's use with cobimetinib for melanoma within six months

- PMLiVE

England’s medicine prices ‘too high’

New analysis finds NICE is too lenient on pharma’s price tags

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links